Cell Line : MDA-MB-415
Cellosaurus Index : CVCL_0621
Cellosaurus ID : MDA-MB-415
CTRP2 Name
: MDAMB415
CCLE Name
: MDAMB415_BREAST
GDSC1 Name
, GDSC2 Name
: MDA-MB-415
Cancer Type : breast
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| MDA-MB-415 | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | 123138 | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | 123829 | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | 150412 | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-415 | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | 5-azacytidine | GDSC2 | 0.0200 | 20.0000 |
|
| MDA-MB-415 | 5-Fluorouracil | GDSC1,GDSC2 | 0.0195 | 32.0000 |
|
| MDA-MB-415 | 50869 | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | 615590 | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | 630600 | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | 667880 | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | 720427 | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | 729189 | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | 741909 | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | 743380 | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | 765771 | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | 776928 | GDSC2 | 0.0300 | 30.0000 |
|
| MDA-MB-415 | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | A-366 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | A-83-01 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-415 | AA-COCF3 | CTRP2 | 0.0081 | 66.0000 |
|
| MDA-MB-415 | ABT737 | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-415 | Acetalax | GDSC2 | 0.0300 | 30.0000 |
|
| MDA-MB-415 | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-415 | Afatinib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| MDA-MB-415 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| MDA-MB-415 | AGK-2 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| MDA-MB-415 | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| MDA-MB-415 | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-415 | Alisertib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| MDA-MB-415 | Alpelisib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | alpha-lipoic acid | GDSC2 | 0.1211 | 121.0000 |
|
| MDA-MB-415 | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| MDA-MB-415 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-415 | Ara-G | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-415 | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| MDA-MB-415 | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| MDA-MB-415 | AS605240 | GDSC1 | 0.0400 | 20.0000 |
|
| MDA-MB-415 | ascorbate (vitamin C) | GDSC2 | 2.0011 | 2000.0000 |
|
| MDA-MB-415 | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-415 | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | AT-406 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | AT13148 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-415 | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| MDA-MB-415 | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | avrainvillamide | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | Axitinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| MDA-MB-415 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | AZD1208 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | AZD1332 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-415 | AZD2014 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | AZD4547 | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| MDA-MB-415 | AZD5153 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | AZD5438 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | AZD5991 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-415 | AZD6482 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-415 | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | AZD7762 | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| MDA-MB-415 | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | AZD8055 | GDSC1,GDSC2 | 0.0010 | 2.0000 |
|
| MDA-MB-415 | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-415 | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | bafilomycin A1 | CTRP2 | 0.0000 | 0.3300 |
|
| MDA-MB-415 | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| MDA-MB-415 | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| MDA-MB-415 | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BDF00022089a | GDSC2 | 0.0050 | 5.0000 |
|
| MDA-MB-415 | BDILV000379a | GDSC2 | 0.0050 | 5.0000 |
|
| MDA-MB-415 | BDOCA000347a | GDSC2 | 0.0020 | 2.0000 |
|
| MDA-MB-415 | BDP-00009066 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Belinostat | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BEN | GDSC2 | 0.0300 | 30.0000 |
|
| MDA-MB-415 | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Bexarotene | GDSC1 | 0.0312 | 8.0000 |
|
| MDA-MB-415 | BI-2536 | GDSC2 | 0.0010 | 10.0000 |
|
| MDA-MB-415 | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | BIBR-1532 | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| MDA-MB-415 | Bicalutamide | GDSC1 | 0.0040 | 10.0000 |
|
| MDA-MB-415 | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Bleomycin | GDSC1,GDSC2 | 0.0020 | 64.0000 |
|
| MDA-MB-415 | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | Bleomycin (50 uM) | GDSC1,GDSC2 | 0.0400 | 50.0000 |
|
| MDA-MB-415 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BMS-345541 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BMS-536924 | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-415 | BMS-754807 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | Bortezomib | GDSC2,CTRP2 | 0.0000 | 0.1300 |
|
| MDA-MB-415 | Bosutinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BPD-00008900 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| MDA-MB-415 | BRD-K04800985 | CTRP2 | 0.0020 | 67.0000 |
|
| MDA-MB-415 | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BRD-K13999467 | CTRP2 | 0.0020 | 67.0000 |
|
| MDA-MB-415 | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BRD-K17060750 | CTRP2 | 0.0020 | 67.0000 |
|
| MDA-MB-415 | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| MDA-MB-415 | BRD-K33199242 | CTRP2 | 0.0020 | 67.0000 |
|
| MDA-MB-415 | BRD-K33514849 | CTRP2 | 0.0010 | 34.0000 |
|
| MDA-MB-415 | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| MDA-MB-415 | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BRD-K63431240 | CTRP2 | 0.0009 | 30.0000 |
|
| MDA-MB-415 | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BRD-K90370028 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| MDA-MB-415 | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-415 | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| MDA-MB-415 | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-415 | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Bromosporine | GDSC2 | 0.0020 | 2.0000 |
|
| MDA-MB-415 | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| MDA-MB-415 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | BX795 | GDSC1 | 0.0195 | 5.0000 |
|
| MDA-MB-415 | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Cabozantinib | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-415 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| MDA-MB-415 | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 48.0000 |
|
| MDA-MB-415 | Carmustine | GDSC2 | 0.0300 | 30.0000 |
|
| MDA-MB-415 | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| MDA-MB-415 | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-415 | CDK9_5038 | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | CDK9_5576 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Cediranib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| MDA-MB-415 | Ch-55 | CTRP2 | 0.0020 | 33.0000 |
|
| MDA-MB-415 | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | CHIR-99021 | GDSC1,CTRP2 | 0.0097 | 80.0000 |
|
| MDA-MB-415 | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| MDA-MB-415 | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Cisplatin | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| MDA-MB-415 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-415 | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| MDA-MB-415 | CPI-637 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Crizotinib | GDSC2,CCLE | 0.0010 | 10.0000 |
|
| MDA-MB-415 | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | CT7033-2 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-415 | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Cytarabine | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| MDA-MB-415 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Dabrafenib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Dacarbazine | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| MDA-MB-415 | Dactinomycin | GDSC2 | 0.0000 | 0.8000 |
|
| MDA-MB-415 | Dactolisib | GDSC1,GDSC2,CTRP2 | 0.0003 | 17.0000 |
|
| MDA-MB-415 | Daporinad | GDSC1,GDSC2 | 0.0001 | 1.0000 |
|
| MDA-MB-415 | Dasatinib | GDSC2 | 0.0010 | 2.0000 |
|
| MDA-MB-415 | Dihydrorotenone | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | Dinaciclib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| MDA-MB-415 | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| MDA-MB-415 | Docetaxel | GDSC1,GDSC2,CTRP2 | 0.0000 | 66.0000 |
|
| MDA-MB-415 | Doramapimod | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-415 | Doxorubicin | GDSC1 | 0.0040 | 5.0000 |
|
| MDA-MB-415 | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Eg5_9814 | GDSC2 | 0.0001 | 0.1000 |
|
| MDA-MB-415 | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Elephantin | GDSC2 | 0.0200 | 20.0000 |
|
| MDA-MB-415 | Elesclomol | GDSC1 | 0.0008 | 0.2000 |
|
| MDA-MB-415 | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| MDA-MB-415 | Entinostat | GDSC2 | 0.0020 | 10.0000 |
|
| MDA-MB-415 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Enzastaurin | GDSC1 | 0.0400 | 20.0000 |
|
| MDA-MB-415 | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | Epirubicin | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| MDA-MB-415 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | ERK_2440 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | ERK_6604 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Erlotinib | GDSC2,CCLE | 0.0020 | 8.0000 |
|
| MDA-MB-415 | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| MDA-MB-415 | Etoposide | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-415 | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Fedratinib | GDSC1,CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-415 | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-415 | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| MDA-MB-415 | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| MDA-MB-415 | Fludarabine | GDSC2 | 0.0200 | 20.0000 |
|
| MDA-MB-415 | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-415 | FMK | GDSC1 | 0.0400 | 20.0000 |
|
| MDA-MB-415 | Foretinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| MDA-MB-415 | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| MDA-MB-415 | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | Gallibiscoquinazole | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Gefitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Gemcitabine | GDSC1,GDSC2 | 0.0001 | 10.0000 |
|
| MDA-MB-415 | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | glutathione | GDSC2 | 0.6403 | 640.0000 |
|
| MDA-MB-415 | GMX-1778 | CTRP2 | 0.0000 | 0.3000 |
|
| MDA-MB-415 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-415 | GSK-J4 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | GSK-LSD1 | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | GSK-LSD1-2HCl | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | GSK1070916 | GDSC1 | 0.0100 | 10.2400 |
|
| MDA-MB-415 | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| MDA-MB-415 | GSK2110183B | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | GSK2256098C | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | GSK2276186C | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | GSK269962A | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-415 | GSK2801 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | GSK2830371 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | GSK2830371A | GDSC2 | 0.0030 | 10.0000 |
|
| MDA-MB-415 | GSK3337463A | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | GSK343 | GDSC2 | 0.0010 | 10.0000 |
|
| MDA-MB-415 | GSK429286A | GDSC1 | 0.0400 | 20.0000 |
|
| MDA-MB-415 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | GSK626616AC | GDSC2 | 0.0001 | 0.1000 |
|
| MDA-MB-415 | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-415 | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-415 | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| MDA-MB-415 | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | HG-5-113-01 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | HG-5-88-01 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | HG-6-71-01 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-415 | HKMTI-1-005 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | I-BET-762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | I-BET151 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | IAP_5620 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | Ibrutinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | IC-87114 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | ICL-SIRT078 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Idelalisib | GDSC1 | 0.0400 | 20.0000 |
|
| MDA-MB-415 | IGF1R_3801 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | IOX2 | GDSC1 | 0.0004 | 0.1000 |
|
| MDA-MB-415 | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| MDA-MB-415 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | IRAK4_4710 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Irinotecan | GDSC2 | 0.0050 | 10.0000 |
|
| MDA-MB-415 | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| MDA-MB-415 | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| MDA-MB-415 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | JAK_8517 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | JAK1_8709 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-415 | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MDA-MB-415 | JQ1 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| MDA-MB-415 | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-415 | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| MDA-MB-415 | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | KU-55933 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-415 | L-685458 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-415 | L-Oxonoreleagnine | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | Lapatinib | GDSC2,CCLE | 0.0025 | 10.0000 |
|
| MDA-MB-415 | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-415 | LCL161 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| MDA-MB-415 | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| MDA-MB-415 | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| MDA-MB-415 | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-415 | LGK974 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| MDA-MB-415 | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Linifanib | GDSC1 | 0.0040 | 1.0240 |
|
| MDA-MB-415 | Linsitinib | GDSC1,GDSC2 | 0.0025 | 10.0000 |
|
| MDA-MB-415 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | LMB_AB1 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | LMB_AB2 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | LMB_AB3 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | LMP744 | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-415 | Luminespib | GDSC1,GDSC2 | 0.0001 | 1.0000 |
|
| MDA-MB-415 | LY2109761 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Masitinib | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| MDA-MB-415 | Methotrexate | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| MDA-MB-415 | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | MG-132 | GDSC2 | 0.0156 | 4.0000 |
|
| MDA-MB-415 | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| MDA-MB-415 | MIM1 | GDSC1,GDSC2 | 0.0100 | 40.0000 |
|
| MDA-MB-415 | MIRA-1 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| MDA-MB-415 | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| MDA-MB-415 | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-415 | Mitoxantrone | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | MK-1775 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | MK-2206 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-415 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| MDA-MB-415 | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-415 | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| MDA-MB-415 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| MDA-MB-415 | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| MDA-MB-415 | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Mycophenolic acid | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | N-acetyl cysteine | GDSC2 | 2.0011 | 2000.0000 |
|
| MDA-MB-415 | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | N25720-51-A1 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | N27922-53-1 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | N29087-69-1 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | N30652-18-1 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| MDA-MB-415 | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | Navitoclax | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| MDA-MB-415 | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Nelarabine | GDSC2 | 0.0200 | 20.0000 |
|
| MDA-MB-415 | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | Nilotinib | GDSC1,GDSC2,CCLE | 0.0020 | 10.0000 |
|
| MDA-MB-415 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-415 | NSC319726 | GDSC1 | 0.0040 | 1.0240 |
|
| MDA-MB-415 | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| MDA-MB-415 | Nutlin-3a | GDSC1,GDSC2,CTRP2,CCLE | 0.0025 | 150.0000 |
|
| MDA-MB-415 | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | NVP-ADW742 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MDA-MB-415 | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Obatoclax Mesylate | GDSC1,GDSC2 | 0.0100 | 16.0000 |
|
| MDA-MB-415 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Olaparib | GDSC1,GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| MDA-MB-415 | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| MDA-MB-415 | OSI-027 | GDSC1,GDSC2 | 0.0039 | 20.0000 |
|
| MDA-MB-415 | OSI-930 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-415 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Oxaliplatin | GDSC2 | 0.0100 | 20.0000 |
|
| MDA-MB-415 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | PAC-1 | GDSC1 | 0.0100 | 2.5600 |
|
| MDA-MB-415 | Paclitaxel | GDSC2,CCLE | 0.0000 | 8.0000 |
|
| MDA-MB-415 | PAK_5339 | GDSC2 | 0.0300 | 30.0000 |
|
| MDA-MB-415 | Palbociclib | GDSC1,GDSC2,CCLE | 0.0025 | 10.0000 |
|
| MDA-MB-415 | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | Panobinostat | GDSC1,CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-415 | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-415 | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-415 | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-415 | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Pazopanib | GDSC1 | 0.0312 | 8.0000 |
|
| MDA-MB-415 | PBD-288 | GDSC2 | 0.0050 | 5.0000 |
|
| MDA-MB-415 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | PD0325901 | GDSC1,GDSC2,CCLE | 0.0003 | 8.0000 |
|
| MDA-MB-415 | PD173074 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| MDA-MB-415 | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-415 | Pemetrexed | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | Pevonedistat | GDSC2,CTRP2 | 0.0023 | 37.0000 |
|
| MDA-MB-415 | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | PF-4708671 | GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-415 | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| MDA-MB-415 | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| MDA-MB-415 | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-415 | PHA-793887 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| MDA-MB-415 | PI-103 | GDSC1,CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-415 | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Pictilisib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| MDA-MB-415 | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | PIK-93 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Piperlongumine | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| MDA-MB-415 | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | PLX-4720 | GDSC1,GDSC2,CCLE | 0.0025 | 10.0000 |
|
| MDA-MB-415 | Podophyllotoxin bromide | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | POMHEX | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| MDA-MB-415 | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| MDA-MB-415 | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-415 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| MDA-MB-415 | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | QL-VIII-58 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | QL-XII-61 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | QS11 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | Quizartinib | GDSC1 | 0.0040 | 1.0240 |
|
| MDA-MB-415 | R428 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | RAF265 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-415 | Rapamycin | GDSC2 | 0.0000 | 0.0200 |
|
| MDA-MB-415 | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| MDA-MB-415 | Ribociclib | GDSC2 | 0.0020 | 4.0000 |
|
| MDA-MB-415 | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | RO-3306 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-415 | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Romidepsin | GDSC2 | 0.0000 | 0.0100 |
|
| MDA-MB-415 | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| MDA-MB-415 | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Rucaparib | GDSC2 | 0.0050 | 5.0000 |
|
| MDA-MB-415 | Ruxolitinib | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| MDA-MB-415 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Sapitinib | GDSC2 | 0.0049 | 10.0000 |
|
| MDA-MB-415 | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-415 | SB216763 | GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-415 | SB505124 | GDSC1 | 0.0391 | 20.0000 |
|
| MDA-MB-415 | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| MDA-MB-415 | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-415 | SCH772984 | GDSC2 | 0.0049 | 5.0000 |
|
| MDA-MB-415 | Schweinfurthin A | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | Selisistat | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Selumetinib | GDSC1,GDSC2,CCLE | 0.0025 | 10.0000 |
|
| MDA-MB-415 | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MDA-MB-415 | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MDA-MB-415 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MDA-MB-415 | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MDA-MB-415 | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MDA-MB-415 | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MDA-MB-415 | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MDA-MB-415 | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MDA-MB-415 | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 100.0000 |
|
| MDA-MB-415 | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MDA-MB-415 | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Sepantronium bromide | GDSC1,GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| MDA-MB-415 | Serdemetan | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | SGC-CBP30 | GDSC2 | 0.0050 | 5.0000 |
|
| MDA-MB-415 | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| MDA-MB-415 | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-415 | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| MDA-MB-415 | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| MDA-MB-415 | Sinularin | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MDA-MB-415 | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | SL0101 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | SN-38 | GDSC1,GDSC2,CTRP2 | 0.0000 | 1.3000 |
|
| MDA-MB-415 | SNX-2112 | GDSC1,CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-415 | Sorafenib | GDSC2,CCLE | 0.0025 | 10.0000 |
|
| MDA-MB-415 | sotrastaurin | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Sphingosine Kinase 1 Inhibitor II | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | SR8278 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| MDA-MB-415 | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | SU11274 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | TAF1_5496 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | TAK-715 | GDSC1 | 0.0400 | 20.0000 |
|
| MDA-MB-415 | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | Tamoxifen | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Tanespimycin | GDSC1,GDSC2,CTRP2,CCLE | 0.0010 | 33.0000 |
|
| MDA-MB-415 | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MDA-MB-415 | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-415 | Taselisib | GDSC2 | 0.0040 | 10.0000 |
|
| MDA-MB-415 | Telomerase Inhibitor IX | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Temozolomide | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| MDA-MB-415 | Teniposide | GDSC2 | 0.0030 | 3.0000 |
|
| MDA-MB-415 | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| MDA-MB-415 | THR-101 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | THR-102 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | THR-103 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-415 | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-415 | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Tivozanib | GDSC1,CTRP2 | 0.0005 | 33.0000 |
|
| MDA-MB-415 | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-415 | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | TL-2-105 | GDSC1 | 0.0200 | 10.2400 |
|
| MDA-MB-415 | Topotecan | GDSC2,CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-415 | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | torin2 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | Tozasertib | GDSC2 | 0.0049 | 5.0000 |
|
| MDA-MB-415 | TPCA-1 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Trametinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| MDA-MB-415 | Tretinoin | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| MDA-MB-415 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| MDA-MB-415 | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| MDA-MB-415 | trifluoperazine | CTRP2 | 0.0041 | 33.0000 |
|
| MDA-MB-415 | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| MDA-MB-415 | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | Tubastatin A | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | TW 37 | GDSC2 | 0.0050 | 5.0000 |
|
| MDA-MB-415 | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | Ulixertinib | GDSC2 | 0.0020 | 10.0000 |
|
| MDA-MB-415 | ULK1_4989 | GDSC2 | 0.0300 | 30.0000 |
|
| MDA-MB-415 | UMI-77 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | UNC0379 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | UNC0638 | GDSC1,GDSC2 | 0.0050 | 40.0000 |
|
| MDA-MB-415 | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| MDA-MB-415 | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| MDA-MB-415 | Uprosertib | GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-415 | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| MDA-MB-415 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| MDA-MB-415 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Veliparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Venetoclax | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| MDA-MB-415 | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| MDA-MB-415 | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-415 | Vinblastine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| MDA-MB-415 | Vincristine | GDSC2,CTRP2 | 0.0030 | 130.0000 |
|
| MDA-MB-415 | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| MDA-MB-415 | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-415 | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Vorinostat | GDSC1,GDSC2 | 0.0049 | 10.0000 |
|
| MDA-MB-415 | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-415 | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | VSP34_8731 | GDSC2 | 0.0300 | 30.0000 |
|
| MDA-MB-415 | VTP-A | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | VTP-B | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-415 | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | VX-680 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| MDA-MB-415 | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | Wee1 Inhibitor | GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-415 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | Wnt-C59 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| MDA-MB-415 | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| MDA-MB-415 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | XAV939 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-415 | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-415 | XMD11-85h | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-415 | XMD8-92 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | YK-4-279 | GDSC2 | 0.0200 | 20.0000 |
|
| MDA-MB-415 | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-415 | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-415 | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| MDA-MB-415 | ZG-10 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-415 | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-415 | ZM447439 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-415 | Zoledronate | GDSC2 | 0.0020 | 2.0000 |
|
| MDA-MB-415 | ZSTK474 | GDSC1 | 0.0200 | 10.2400 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC